Cochrane Abstracts
Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis New search for studies and content updated (conclusions changed)
Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis New search for studies and content updated (conclusions changed) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Non‐absorbable Disaccharides Versus Placebo/no Intervention and Lactulose Versus Lactitol for the Prevention and Treatment of Hepatic Encephalopathy in People With Cirrhosis New Search for Studies and Content Updated (conclusions Changed)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434060/all/Publication_bias_in_clinical_trials_due_to_statistical_significance_or_direction_of_trial_results_Unchanged. Accessed 29 November 2022.
Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis New search for studies and content updated (conclusions changed). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434060/all/Publication_bias_in_clinical_trials_due_to_statistical_significance_or_direction_of_trial_results_Unchanged. Accessed November 29, 2022.
Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis New search for studies and content updated (conclusions changed). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434060/all/Publication_bias_in_clinical_trials_due_to_statistical_significance_or_direction_of_trial_results_Unchanged
Non‐absorbable Disaccharides Versus Placebo/no Intervention and Lactulose Versus Lactitol for the Prevention and Treatment of Hepatic Encephalopathy in People With Cirrhosis New Search for Studies and Content Updated (conclusions Changed) [Internet]. In: Cochrane Abstracts. [cited 2022 November 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434060/all/Publication_bias_in_clinical_trials_due_to_statistical_significance_or_direction_of_trial_results_Unchanged.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis New search for studies and content updated (conclusions changed)
ID - 434060
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434060/all/Publication_bias_in_clinical_trials_due_to_statistical_significance_or_direction_of_trial_results_Unchanged
DB - Evidence Central
DP - Unbound Medicine
ER -
